SCHEMBL240170

SCHEMBL240170

NC(=O)[C@@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572346 1.00
SCHEMBL221055 1.00
Bromide SCHEMBL7327552 0.98 GLI1 (0.59)
Hydrochloric Acid SCHEMBL6976932 0.98 GLI1 (0.59)
Hydrochloric Acid SCHEMBL30937515 0.98
Hydrochloric Acid SCHEMBL25236164 0.98 GLI1 (0.59)
Bromide SCHEMBL7327555 0.98 GLI1 (0.59)
Hydrochloric Acid SCHEMBL4316344 0.98
Hydrochloric Acid SCHEMBL241228 0.98
Hydrochloric Acid SCHEMBL241227 0.98

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3365 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079850-A Preparation method of high-purity vildagliptin intermediate and disubstituted impurity thereof 2026-05-26 CN claimed
EP-4293024-B1 QUINAZOLINE COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEIN ASTELLAS PHARMA INC (JP) 2026-04-08 EP claimed
US-20260083865-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2026-03-26 US claimed
EP-4709378-A1 COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2026-03-18 EP claimed
CN-121574231-A Canagliptin peptide semisynthetic preparation method 福建基诺厚普生物科技有限公司 2026-02-27 CN claimed
US-20260027071-A1 COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND (KR) 2026-01-29 US claimed
EP-4613745-A2 PROCESS FOR PREPARING A COT INHIBITOR COMPOUND Gilead Sciences, Inc. (US) 2025-09-10 EP claimed
US-12365666-B2 Process for preparing a Cot inhibitor compound GILEAD SCIENCES, INC. (US) 2025-07-22 US claimed
EP-4583917-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B Pharmaceuticals GmbH (DE) 2025-07-16 EP claimed
CN-119350469-B Method for synthesizing CAGRILINTIDE by large fragment SPPS-LPPS mixing method 杭州诺澳生物医药科技有限公司 2025-05-23 CN claimed
US-4652627-A BLOOD METAL CONCENTRATIONS KEMPE TOMAS G (US) 1987-03-24 US claimed
US-4644054-A LOWERING BLOOD CALCIUM KEMPE TOMAS G 1987-02-17 US claimed
EP-0203031-A2 Biologically active lysine containing octapeptides The Administrators of The Tulane University Educational Fund (US) 1986-11-26 EP claimed
EP-0197794-A2 Preparation of peptides with C-terminal proline amide SANKYO COMPANY LIMITED (JP) 1986-10-15 EP claimed
EP-0194443-A2 Novel peptides, compositions containing them and processes for their production TANABE SEIYAKU CO., LTD. (JP) 1986-09-17 EP claimed
EP-0168042-A2 Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them TANABE SEIYAKU CO., LTD. (JP) 1986-01-15 EP claimed
EP-0151166-A1 NOVEL PEPTIDE HORMONES WITH CALCITONIN-LIKE ACTIVITY Kaiser, Bonnie L. (US) 1985-08-14 EP claimed
WO-1985000165-A1 NOVEL PEPTIDE HORMONES WITH CALCITONIN-LIKE ACTIVITY UNIVERSITY PATENTS, INCORPORATED (US) 1985-01-17 WO claimed
US-4288432-A ANALGESICS RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1981-09-08 US claimed
US-4045556-A ANTIDEPRESSANTS, PYSCHOSTIMULANTS; SILYLATION SCHWERTNER EBERHARD 1977-08-30 US claimed